Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FKEKG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,623
Award facts
- Contract value 100% obligated
- $8,622.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,622.72 by the Defense Logistics Agency (DLA) on August 18, 2025. The delivery order, which carries a firm fixed-price structure with an ultimate completion date of August 19, 2025, is for 120 capsules of Xtandi 40 mg, an oncology medication used in cancer treatment. This award was issued without a set-aside designation, demonstrating the company's competitive capability in open federal procurement markets. The place of performance is located at the contractor's facility in Park Ridge, Illinois.
This delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA through the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for prescription medications, biologics, and medical consumables supporting military health facilities worldwide. DMS Pharmaceutical Group's portfolio of DLA contracts demonstrates its established role as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of specialty medications and pharmacy services to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FKEKG?
SPE2DB25FKEKG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FKEKG worth?
The government has obligated $8,623 on SPE2DB25FKEKG.
Is contract SPE2DB25FKEKG an order under another contract?
Yes. SPE2DB25FKEKG is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEKG competed?
The extent of competition for SPE2DB25FKEKG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award